pargyline has been researched along with Breast Neoplasms in 8 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Among the steroid substrate analogs, 4-hydroxyandrostenedione has been shown to be effective in breast cancer patients with advanced disease and was recently approved for treatment in the United Kingdom." | 4.78 | Aromatase, its inhibitors and their use in breast cancer treatment. ( Brodie, AM, 1993) |
| "Treatment of ER-positive xenograft-based breast tumors with PELP1-siRNA-DOPC or pargyline reduced tumor volume by 58." | 1.38 | Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer. ( Cortez, V; Lopez-Berestein, G; Mann, M; Miyata, N; Rodriguez-Aguayo, C; Sood, AK; Suzuki, T; Tekmal, S; Vadlamudi, RK, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bansode, P | 1 |
| Anantacharya, R | 1 |
| Dhanavade, M | 1 |
| Kamble, S | 1 |
| Barale, S | 1 |
| Sonawane, K | 1 |
| Satyanarayan, ND | 1 |
| Rashinkar, G | 1 |
| Pollock, JA | 1 |
| Larrea, MD | 1 |
| Jasper, JS | 1 |
| McDonnell, DP | 1 |
| McCafferty, DG | 1 |
| Cortez, V | 1 |
| Mann, M | 1 |
| Tekmal, S | 1 |
| Suzuki, T | 1 |
| Miyata, N | 1 |
| Rodriguez-Aguayo, C | 1 |
| Lopez-Berestein, G | 1 |
| Sood, AK | 1 |
| Vadlamudi, RK | 1 |
| Vasilatos, SN | 1 |
| Katz, TA | 1 |
| Oesterreich, S | 1 |
| Wan, Y | 1 |
| Davidson, NE | 1 |
| Huang, Y | 1 |
| MacIndoe, JH | 1 |
| Woods, GR | 1 |
| Etre, LA | 1 |
| Covey, DF | 3 |
| Perel, E | 1 |
| Davis, SP | 1 |
| Killinger, DW | 1 |
| Brodie, AM | 1 |
| Brandt, ME | 1 |
| Puett, D | 1 |
| Garola, R | 1 |
| Fendl, K | 1 |
| Zimniski, SJ | 1 |
2 reviews available for pargyline and Breast Neoplasms
| Article | Year |
|---|---|
Aromatase, its inhibitors and their use in breast cancer treatment.
Topics: Aminoglutethimide; Androstenedione; Antineoplastic Agents; Aromatase; Aromatase Inhibitors; Breast N | 1993 |
Aromatase and aromatase inhibitors: from enzymology to selective chemotherapy.
Topics: Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Female; Humans; Neoplas | 1988 |
6 other studies available for pargyline and Breast Neoplasms
| Article | Year |
|---|---|
Evaluation of drug candidature: In silico ADMET, binding interactions with CDK7 and normal cell line studies of potentially anti-breast cancer enamidines.
Topics: Amines; Animals; Antineoplastic Agents; Azides; Binding Sites; Breast Neoplasms; Cell Proliferation; | 2019 |
Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERĪ±-dependent and -independent manners.
Topics: Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Estrogen Receptor alpha; | 2012 |
Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.
Topics: Animals; Benzamides; Breast Neoplasms; Carcinogens; Cell Line, Tumor; Cell Proliferation; Co-Repress | 2012 |
Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Breast Neoplasms; Cadherins; Cell Line, Tumor; Cell Prolif | 2013 |
Comparative studies of aromatase inhibitors in cultured human breast cancer cells.
Topics: Aminoglutethimide; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Cell Line; Dihydrotestos | 1982 |
Effects of 4-hydroxy-4-androstene-3, 17-dione and 10-propargylestr-4-ene-3, 17-dione on the metabolism of androstenedione in human breast carcinoma and breast adipose tissues.
Topics: Adipose Tissue; Androstenedione; Breast; Breast Neoplasms; Female; Humans; Kinetics; Pargyline | 1981 |